MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

March 2003


Drug Safety Revisions: FDA Update

The author reviews the reasons for FDA labeling changes for estrogens and estrogen–progesterone combinations as hormonal therapy; sertraline for depression; and palivizumab as prophylactic therapy for respiratory infections.
Marvin M. Goldenberg, PhD, RPh, MS

Chronic Pain Management in Managed Care Organizations: A National Survey of Medical Directors

The authors present the results of a survey sent to the directors of MCOs to ascertain their views on chronic pain in their patients.
Chureen Carter, PharmD, Neil I. Goldfarb, Christine W. Hartmann, MSS, Adam R. Roumm, Susan M. Vallow, MBA, MA, and Michael Durkin, MS

Ezetimibe: The First Cholesterol Absorption Inhibitor

The first of the new selective cholesterol absorption inhibitors, ezetimibe has been approved for several indications.
Beata M. Domagala, PharmD, Michelle Leady, PharmD, and Daniel S. Streetman, PharmD

Cover Story

Looking Ahead: Recommendations for Planning and Improving Adult Vaccination Programs

Now is the time to order vaccine for the fall flu season. The authors discuss the ways in which many diseases in older adults could be prevented with more effective immunization strategies.
S. Jay Weaver, PharmD, and Paul L. Doering, MS Pharm



“Transparent” Power: The New Milliman Guidelines

David B. Nash, MD, MBA


Editor’s Memo: Online at Last!

P&T is now accessible on the World Wide Web. But wait, there’s more!
Sonja Sherritze

Medication Errors

“Magic Words” or “Red Flags?”

Matthew Grissinger discusses some key words that should be considered “red flags.”
Matthew Grissinger

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

P&T Snapshot

Select SSRIs Increase Level of HMO Drug Formulary Access Despite Generic Incursion

Prescription Washington

Incremental Progress Improving Medication Administration

Stephen Barlas ponders the tragic loss of life caused by a medical error.
Stephen Barlas

Drug Forecast

Interferon beta-1a in the Treatment of Multiple Sclerosis

Dr. Liang-Kim reviews the role of interferon beta-1a in multiple sclerosis.
Kathleen S. Liang-Kim, RPh

P&T Snapshot

Medical Errors: Facing the Numbers